1. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. (January 2019) Authors: D'Souza, Deepak Cyril; Cortes-Briones, Jose; Creatura, Gina; Bluez, Grai; Thurnauer, Halle; Deaso, Emma; Bielen, Kim; Surti, Toral; Radhakrishnan, Rajiv; Gupta, Aarti; Gupta, Swapnil; Cahill, John; Sherif, Mohamed A; Makriyannis, Alexandros; Morgan, Peter T; Ranganathan, Mohini; Skosnik, Patrick D Journal: Lancet Issue: Volume 6:Number 1(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗